Effect of Metformin/Irinotecan-loaded Poly-Lactic Acid Nanoparticles on Glioblastoma: in Vitro and in Vivo Studies

dc.contributor.author Taghizadehghalehjoughi, Ali
dc.contributor.author Hacimuftuoglu, Ahmet
dc.contributor.author Cetin, Meltem
dc.contributor.author Ugur, Afife Busra
dc.contributor.author Galateanu, Bianca
dc.contributor.author Mezhuev, Yaroslav
dc.contributor.author Abd El-Aty, A. M.
dc.date.accessioned 2025-05-10T17:05:06Z
dc.date.available 2025-05-10T17:05:06Z
dc.date.issued 2018
dc.description Hacimuftuoglu, Ahmet/0000-0002-9658-3313; Abd El-Aty, A. M./0000-0001-6596-7907; Stivaktakis, Polychronis/0000-0001-6004-2948; Nalci, Kemal Alp/0000-0003-3786-5246; Tsatsakis, Aristidis/0000-0003-3824-2462 en_US
dc.description.abstract Aim: The present study was designed to evaluate the effects of irinotecan hydrochloride (IRI)- or metformin hydrochloride (MET)-loaded poly-lactic-co-glycolic acid (PLGA) nanoparticles (NPs) for the treatment of glioblastoma multiforme using in vitro neuron and U-87 MG glioblastoma cell cultures and in vivo animal model. Methods: The cytotoxic and neurotoxic effects of pure drugs, blank NPs and MET- and IRI-loaded PLGA NPs were investigated in vitro (using methylthiazolyldiphenyl-tetrazolium bromide assay) and in vivo (using Cavalieri's principle for estimation of cancer volume). Results: 1 and 2 mM doses of MET and MET-loaded PLGA NPs, respectively, significantly reduced the volume of extracted cancer. Conclusion: Consequently, MET- and IRI-loaded PLGA NPs may be a promising approach for the treatment of glioblastoma multiforme. en_US
dc.description.sponsorship Scientific and Technological Research Council of Turkey (TUBITAK) [113S083] en_US
dc.description.sponsorship This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK, Project Number: 113S083). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. en_US
dc.identifier.doi 10.2217/nnm-2017-0386
dc.identifier.issn 1743-5889
dc.identifier.issn 1748-6963
dc.identifier.scopus 2-s2.0-85050696817
dc.identifier.uri https://doi.org/10.2217/nnm-2017-0386
dc.identifier.uri https://hdl.handle.net/20.500.14720/6212
dc.language.iso en en_US
dc.publisher Future Medicine Ltd en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Brain Tumor en_US
dc.subject Cavalieri'S Principle en_US
dc.subject Irinotecan en_US
dc.subject Metformin en_US
dc.subject Nanoparticles en_US
dc.subject Plga en_US
dc.title Effect of Metformin/Irinotecan-loaded Poly-Lactic Acid Nanoparticles on Glioblastoma: in Vitro and in Vivo Studies en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Hacimuftuoglu, Ahmet/0000-0002-9658-3313
gdc.author.id Abd El-Aty, A. M./0000-0001-6596-7907
gdc.author.id Stivaktakis, Polychronis/0000-0001-6004-2948
gdc.author.id Nalci, Kemal Alp/0000-0003-3786-5246
gdc.author.id Tsatsakis, Aristidis/0000-0003-3824-2462
gdc.author.scopusid 56444330700
gdc.author.scopusid 6602395368
gdc.author.scopusid 36088991000
gdc.author.scopusid 57203146871
gdc.author.scopusid 35388271400
gdc.author.scopusid 57214030248
gdc.author.scopusid 7402046023
gdc.author.wosid Okkay, Ufuk/Abc-2672-2021
gdc.author.wosid Mezhuev, Yaroslav/F-8596-2017
gdc.author.wosid Ghaffari, Mohammad/B-7840-2019
gdc.author.wosid Çetin, Meltem/Abi-4879-2020
gdc.author.wosid Ugur Kaplan, Afife Busra/Aay-2218-2021
gdc.author.wosid Taşpinar, Mehmet/Lig-3987-2024
gdc.author.wosid Tsatsakis, Aristidis/H-2890-2013
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.description.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
gdc.description.departmenttemp [Taghizadehghalehjoughi, Ali] Ataturk Univ, Dept Pharmacol & Toxicol, Fac Vet Sci, TR-25240 Erzurum, Turkey; [Hacimuftuoglu, Ahmet; Okkay, Ufuk; Taspinar, Numan; Mohammadzadeh, Maryam; Nalci, Kemal Alp; Abd El-Aty, A. M.] Ataturk Univ, Dept Med Pharmacol, Fac Med, TR-25240 Erzurum, Turkey; [Cetin, Meltem; Ugur, Afife Busra] Ataturk Univ, Dept Pharmaceut Technol, Fac Pharm, TR-25240 Erzurum, Turkey; [Galateanu, Bianca] Dept Biochem & Mol Biol, 91-95 Splaiul Independentei,Dist 5, Bucharest 050095, Romania; [Mezhuev, Yaroslav] D Mendeleev Univ Chem Technol Russia, Ctr Biomat, Miusskaya Sq 9, Moscow 125047, Russia; [Taspinar, Mehmet] Yuzuncu Yil Univ, Sch Med, Dept Med Biol, Van, Turkey; [Uyanik, Abdullah] Ataturk Univ, Dept Nephrol, Fac Med, TR-25240 Erzurum, Turkey; [Gundogdu, Betul] Ataturk Univ, Dept Pathol, Fac Med, TR-25240 Erzurum, Turkey; [Stivaktakis, Polychronis; Tsatsakis, Aristidis] Univ Crete, Toxicol Lab, Sch Med, Iraklion 71003, Greece; [Stivaktakis, Polychronis; Tsatsakis, Aristidis] Univ Crete Spin Off, Toxplus SA, Iraklion 71601, Greece; [Jung, Tae Woo] Seoul Natl Univ, Res Adm Team, Bundang Hosp, Gyeonggi, South Korea; [Jeong, Ji Hoon] Chung Ang Univ, Dept Pharmacol, Coll Med, Seoul, South Korea; [Abd El-Aty, A. M.] Cairo Univ, Dept Pharmacol, Fac Vet Med, Giza 12211, Egypt en_US
gdc.description.endpage 1606 en_US
gdc.description.issue 13 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 1595 en_US
gdc.description.volume 13 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q1
gdc.identifier.pmid 30028222
gdc.identifier.wos WOS:000441781300007
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed

Files